Annexin A1: A central player in the anti-inflammatory and neuroprotective role of microglia

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6317-6328

  McArthur, Simon ^a   Cristante, Enrico ^a   Paterno, Mario ^a   Christian, Helen ^c   Roncaroli, Federico ^b   Gillies, Glenda E ^a   Solito, Egle ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Charing Cross Campus   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; LIPOCORTIN 1; PHOSPHATIDYLSERINE;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN; CELL ACTIVATION; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROGLIA; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CELL LINE; CELL SEPARATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; MICROGLIA; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PHAGOCYTOSIS;

EID: 78650666213     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001095     Document Type: Article

References (72)

1. Ransohoff, R. M., and V. H. Perry. 2009. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27:119-145.
2. Nimmerjahn, A., F. Kirchhoff, and F. Helmchen. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
3. Brown, G. C., and J. J. Neher. 2010. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41:242-247.
4. Glezer, I., J. C. Bittencourt, and S. Rivest. 2009. Neuronal expression of Cd36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits. J. Comp. Neurol. 517:906-924.
5. Rivest, S. 2009. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9:429-439.
6. Garden, G. A., and T. Möller. 2006. Microglia biology in health and disease. J. Neuroimmune Pharmacol. 1:127-137.
7. Stolzing, A., and T. Grune. 2004. Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells. FASEB J. 18:743-745.
8. Witting, A., P. Müller, A. Herrmann, H. Kettenmann, and C. Nolte. 2000. Phagocytic clearance of apoptotic neurons by microglia/brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidy lserine-mediated recognition. J. Neurochem. 75:1060-1070.
9. Silva, M. T., A. do Vale, and N. M. dos Santos. 2008. Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis 13:463-482.
10. Ren, Y., and J. Savill. 1998. Apoptosis: the importance of being eaten. Cell Death Differ. 5:563-568.
11. Lauber, K., S. G. Blumenthal, M. Waibel, and S. Wesselborg. 2004. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 14:277-287.
12. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9:62-70.
13. Maderna, P., S. Yona, M. Perretti, and C. Godson. 2005. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasonetreated macrophages and annexin-derived peptide Ac (2-26). J. Immunol. 174:3727-3733.
14. Morimoto, K., W. J. Janssen, M. B. Fessler, K. A. McPhillips, V. M. Borges, R. P. Bowler, Y. Q. Xiao, J. A. Kench, P. M. Henson, and R. W. Vandivier. 2006. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J. Immunol. 176:7657-7665.
15. H, freezing, and dehydration. J. Histochem. Cytochem. 45:527-538.
16. Dreier, R., K. W. Schmid, V. Gerke, and K. Riehemann. 1998. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem. Cell Biol. 110:137-148.
17. Solito, E., S. McArthur, H. Christian, F. Gavins, J. C. Buckingham, and G. E. Gillies. 2008. Annexin A1 in the brain-undiscovered roles? Trends Pharmacol. Sci. 29:135-142.
18. Probst-Cousin, S., D. Kowolik, K. Kuchelmeister, C. Kayser, B. Neundörfer, and D. Heuss. 2002. Expression of annexin-1 in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 28:292-300.
19. Knott, C., G. Stern, and G. P. Wilkin. 2000. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2. Mol. Cell. Neurosci. 16:724-739.
20. de Coupade, C., M. N. Ajuebor, F. Russo-Marie, M. Perretti, and E. Solito. 2001. Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am. J. Pathol. 159:1435-1443.
21. Szabó, C., C. Thiemermann, C. C. Wu, M. Perretti, and J. R. Vane. 1994. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. USA 91:271-275.
22. Linke, R. P., R. Oos, N. M. Wiegel, and W. B. Nathrath. 2006. Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem. 108:197-208.
23. Blasi, E., R. Barluzzi, V. Bocchini, R. Mazzolla, and F. Bistoni. 1990. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27:229-237.
24. Henn, A., S. Lund, M. Hedtjärn, A. Schrattenholz, P. Pörzgen, and M. Leist. 2009. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26:83-94.
25. Greene, L. A., and A. S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
26. Glinka, Y. Y., and M. B. Youdim. 1995. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 292:329-332.
27. Blum, D., S. Torch, M. F. Nissou, and J. M. Verna. 2001. 6-Hydroxydopamine-induced nuclear factor-κB activation in PC12 cells. Biochem. Pharmacol. 62:473-481.
28. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidy lserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
29. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson, and C. Haslett. 1989. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83:865-875.
30. Solito, E., A. Kamal, F. Russo-Marie, J. C. Buckingham, S. Marullo, and M. Perretti. 2003. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17:1544-1546.
31. de Haas, A. H., H. W. Boddeke, N. Brouwer, and K. Biber. 2007. Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia 55:1374-1384.
32. Ponomarev, E. D., M. Novikova, K. Maresz, L. P. Shriver, and B. N. Dittel. 2005. Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J. Immunol. Methods 300:32-46.
33. Solito, E., H. C. Christian, M. Festa, A. Mulla, T. Tierney, R. J. Flower, and J. C. Buckingham. 2006. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 20:1498-1500.
34. Solito, E., C. de Coupade, L. Parente, R. J. Flower, and F. Russo-Marie. 1998. Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ. 9:327-336.
35. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
36. John, C. D., V. Sahni, D. Mehet, J. F. Morris, H. C. Christian, M. Perretti, R. J. Flower, E. Solito, and J. C. Buckingham. 2007. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J. 21:1037-1046.
37. McArthur, S., S. Yazid, H. Christian, R. Sirha, R. Flower, J. Buckingham, and E. Solito. 2009. Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J. 23:4000-4010.
38. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
39. Pepinsky, R. B., L. K. Sinclair, I. Dougas, C. M. Liang, P. Lawton, and J. L. Browning. 1990. Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett. 261:247-252.
40. Lim, L. H., E. Solito, F. Russo-Marie, R. J. Flower, and M. Perretti. 1998. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. USA 95:14535-14539.
41. Solito, E., C. Raguenes-Nicol, C. de Coupade, A. Bisagni-Faure, and F. Russo-Marie. 1998. U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br. J. Pharmacol. 124:1675-1683.
42. Parente, L., and E. Solito. 2004. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 53:125-132.
43. Scannell, M., M. B. Flanagan, A. deStefani, K. J. Wynne, G. Cagney, C. Godson, and P. Maderna. 2007. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178:4595-4605.
44. 1 integrin. J. Immunol. 165:1573-1581.
45. 2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem. J. 266:195-200.
46. Rosengarth, A., V. Gerke, and H. Luecke. 2001. X-ray structure of full-length annexin 1 and implications for membrane aggregation. J. Mol. Biol. 306:489-498.
47. Tierney, T., H. C. Christian, J. F. Morris, E. Solito, and J. C. Buckingham. 2003. Evidence from studies on co-cultures of TtT/GF and AtT20 cells that annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. J. Neuroendocrinol. 15:1134-1143.
48. Moss, S. E., and R. O. Morgan. 2004. The annexins. Genome Biol. 5:219
49. Perretti, M., N. Chiang, M. La, I. M. Fierro, S. Marullo, S. J. Getting, E. Solito, and C. N. Serhan. 2002. Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8:1296-1302.
50. Stenfeldt, A. L., J. Karlsson, C. Wennerås, J. Bylund, H. Fu, and C. Dahlgren. 2007. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30:224-229.
51. Liu, Y., S. Walter, M. Stagi, D. Cherny, M. Letiembre, W. Schulz-Schaeffer, H. Heine, B. Penke, H. Neumann, and K. Fassbender. 2005. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128:1778-1789.
52. Hayhoe, R. P., A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti. 2006. Annexin 1 and its bioactive peptide inhibit neutrophil- endothelium interactions under flow: indication of distinct receptor involvement. Blood 107:2123-2130.
53. Jana, M., C. A. Palencia, and K. Pahan. 2008. Fibrillar amyloid-β peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol. 181:7254-7262.
54. Perry, V. H., J. A. Nicoll, and C. Holmes. 2010. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6:193-201.
55. Chan, A., T. Magnus, and R. Gold. 2001. Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system. Glia 33:87-95.
56. Magnus, T., A. Chan, O. Grauer, K. V. Toyka, and R. Gold. 2001. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 167:5004-5010.
57. Napoli, I., and H. Neumann. 2009. Microglial clearance function in health and disease. Neuroscience 158:1030-1038.
58. Suh, H., W. Deng, and F. H. Gage. 2009. Signaling in adult neurogenesis. Annu. Rev. Cell Dev. Biol. 25:253-275.
59. Dayer, A. G., A. A. Ford, K. M. Cleaver, M. Yassaee, and H. A. Cameron. 2003. Short-term and long-term survival of new neurons in the rat dentate gyrus. J. Comp. Neurol. 460:563-572.
60. Lawson, L. J., V. H. Perry, P. Dri, and S. Gordon. 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151-170.
61. Migeotte, I., D. Communi, and M. Parmentier. 2006. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17:501-519.
62. Gastardelo, T. S., A. S. Damazo, J. Dalli, R. J. Flower, M. Perretti, and S. M. Oliani. 2009. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am. J. Pathol. 174:177-183.
63. Tiffany, H. L., M. C. Lavigne, Y. H. Cui, J. M. Wang, T. L. Leto, J. L. Gao, and P. M. Murphy. 2001. Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276:23645-23652.
64. Cui, Y. H., Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang. 2002. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168:434-442.
65. Brandenburg, L. O., M. Konrad, C. J. Wruck, T. Koch, R. Lucius, and T. Pufe. 2010. Functional and physical interactions between formyl-peptidereceptors and scavenger receptor MARCO and their involvement in amyloid β1-42-induced signal transduction in glial cells. J. Neurochem. 113:749-760.
66. Alarcón, R., C. Fuenzalida, M. Santibáñez, and R. von Bernhardi. 2005. Expression of scavenger receptors in glial cells: comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound β-amyloid. J. Biol. Chem. 280:30406-30415.
67. Cui, Y., Y. Le, H. Yazawa, W. Gong, and J. M. Wang. 2002. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72:628-635.
68. Mulla, A., C. Leroux, E. Solito, and J. C. Buckingham. 2005. Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J. Clin. Endocrinol. Metab. 90:557-562.
69. Garcia Pedrero, J. M., M. P. Fernandez, R. O. Morgan, A. Herrero Zapatero, M. V. Gonzalez, C. Suarez Nieto, and J. P. Rodrigo. 2004. Annexin A1 downregulation in head and neck cancer is associated with epithelial differentiation status. Am. J. Pathol. 164:73-79.
70. Akiyama, H., S. Barger, S. Barnum, B. Bradt, J. Bauer, G. M. Cole, N. R. Cooper, P. Eikelenboom, M. Emmerling, B. L. Fiebich, et al. 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383-421.
71. McGeer, P. L., and E. G. McGeer. 2004. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 (Suppl. 1): S3-S7.
72. McQualter, J. L., and C. C. Bernard. 2007. Multiple sclerosis: a battle between destruction and repair. J. Neurochem. 100:295-306.